Lärarfond 21-44 år vs UBS Lux Equity Fund Biotech USD

Lärarfond 21-44 år vs UBS Lux Equity Fund Biotech USD

1. Lärarfond 21-44 år

  • Security

    Lärarfond 21-44 år

  • Fee

    0.60%

  • ISIN

    SE0001112749

  • Holdings

    26

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 36 holdings in Lärarfond 21-44 år, where the largest holding is AstraZeneca (3.04), followed by Volvo (2.87) and Atlas Copco (2.83). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.35) and Moderna (9.21).

All Holdings

Here we compare the holdings in Lärarfond 21-44 år and UBS Lux Equity Fund Biotech USD.

Lärarfond 21-44 år UBS Lux Equity Fund Biotech USD
1. AstraZeneca
Sweden UK
3.04 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Volvo B
Sweden
2.87 %
2. Vertex Pharmaceuticals Inc
9.35 %
3. Atlas Copco B
Sweden
2.83 %
3. Moderna Inc
9.21 %
4. Investor B
Sweden
2.79 %
4. Alnylam Pharmaceuticals Inc
6.96 %
5. Hexagon B
Sweden
2.58 %
5. AbbVie Inc
USA
5.53 %
6. Swedbank A
Sweden
2.21 %
6. Gilead Sciences Inc
USA
4.66 %
7. Microsoft Corp
USA
2.2 %
7. Amgen Inc
4.3 %
8. Nordea Bank Abp
Finland
2.09 %
8. BioNTech SE
4.13 %
9. Swedish Orphan Biovitrum AB
Sweden
1.98 %
9. Karuna Therapeutics Inc
3.75 %
10. Assa Abloy B
Sweden
1.71 %
10. Royalty Pharma Plc
3.37 %
11. SKF B
Sweden
1.69 %
-
12. Ericsson B
Sweden
1.65 %
-
13. Alfa Laval
Sweden
1.63 %
-
14. Getinge B
Sweden
1.59 %
-
15. Epiroc A
Sweden
1.52 %
-
16. Beijer Ref B
Sweden
1.49 %
-
17. EQT AB
Sweden
1.47 %
-
18. Nvidia Corp
USA
1.41 %
-
19. Alphabet Inc Class A
USA
1.38 %
-
20. Sandvik
Sweden
1.31 %
-
21. Apple Inc
USA
1.27 %
-
22. Tele2 B
Sweden
1.2 %
-
23. Fast. Balder B
Sweden
1.2 %
-
24. SEB A
Sweden
1.19 %
-
25. Amazon.com Inc
USA
1.17 %
-
26. Essity B
Sweden
1.17 %
-

The list of fund holdings was last updated on June 5, 2025.